BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 05, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Corlux mifepristone: Completed Phase III enrollment

Corcept completed enrollment of 50 patients in an open-label, U.S. Phase III trial evaluating oral Corlux given once daily for 24...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >